Loading data for EMBC — first visit, this takes a few seconds.
Embecta Corp. (EMBC)
NasdaqGS: EMBC
· 即時價格 · USD
4.94
+0.05 (1.02%)
收盤價： Sep 11, 2026, 3:59 PM
5.03
+1.82%
盤後: 7:30 PM
股價、關鍵數字和最新消息，都在這一頁。
Embecta Corp.（EMBC）股價、分析與資料
1.02% (1D)
| 買價 | 4.91 |
| 市值 | 280M |
| 營收 (ttm) | 1.02B |
| 淨利（ttm） | 87.5M |
| 0.85 | |
| 1.47 | |
| 3.36 | |
| 2.8 | |
| P/B (ttm) | -0.46 |
| P/S (ttm) | 0.27 |
| 財報日期 | Nov 25, 2026 |
| 賣價 | 6.32 |
| 成交量 | 1,132,620 |
| 20 日平均成交量 | 1,835,948 |
| 開盤價 | 4.93 |
| 前收盤價 | 4.89 |
| 當日區間 | 4.89 - 5.04 |
| 52 週範圍 | 2.77 - 15.55 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | $0.04 (0.81%) |
| 除息日 | Aug 27, 2026 |
關於 EMBC
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, In...
完整的公司簡介財報驚奇
Embecta 已於 Aug 7, 2026 公布季度財報：
- 營收為 $271.7M 低於預期 $0, 年增 -8.05% 下滑.
- 每股盈餘為 0.56 超出預期 0.29, 年增 -50.00% 下滑.
第 1 頁，共 2 頁